Lycoread
—
May 30 2024 | by Sarah Khaldi
Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer
In a prospective study we evaluated the efficacy of lycopene for the treatment of patients with metastatic hormone refractory prostate cancer.
File Type:
www
Categories:
Lycomato